Cargando…
MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells
Numerous studies have described the critical role played by microRNAs (miRNAs) in cancer progression and the potential of these small non-coding RNAs for diagnostic or therapeutic applications. However, the mechanisms responsible for the altered expression of miRNAs in malignant cells remain poorly...
Autores principales: | Gailhouste, Luc, Liew, Lee Chuen, Yasukawa, Ken, Hatada, Izuho, Tanaka, Yasuhito, Kato, Takashi, Nakagama, Hitoshi, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639415/ https://www.ncbi.nlm.nih.gov/pubmed/31320614 http://dx.doi.org/10.1038/s41419-019-1788-6 |
Ejemplares similares
-
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
por: Gailhouste, Luc, et al.
Publicado: (2018) -
Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
por: Gailhouste, Luc, et al.
Publicado: (2018) -
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
por: Morita, Sumiyo, et al.
Publicado: (2013) -
CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors
por: Zhang, Yiqun, et al.
Publicado: (2016) -
MicroRNA‐493‐5p‐mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion
por: Yasukawa, Ken, et al.
Publicado: (2020)